Physician profile
Lawrence Wagman
NPI 1720180383
$2,341.49
in general payments reported to CMS, 2019-2025
6 companies · $752 in 2025
The $752 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2021: $1,129 · 2023: $161 · 2024: $156 · 2025: $752.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575 · Travel and Lodging: $494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.92 |
| Travel and Lodging | $494.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,000.00 | 2021 | |
| Stryker Corporation | $880.76 | 2021-2025 | 1788, Molli, Spy-Phi System |
| Medtronic, INC. | $161.42 | 2023 | Signia |
| Molli Surgical (US) INC | $155.76 | 2024 | |
| Genentech USA, INC. | $143.55 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Wagman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.